Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets:
Cash and cash equivalents	$ 434	$ 78
Other assets	0	0
Total assets	434	78
Liabilities:
Accounts payable and accrued liabilities	1,713	3,225
Loan(s) payable - related party	0	3,198
Total liabilities	1,713	6,423
Commitments and contingencies (Note 6)
Stockholders' equity (deficit):
Common stock ($0.01 par value, 85,000 authorized in 2024 and 85,000 authorized in 2023, 84,938 issued and 84,938 outstanding in 2024 and 46,410 issued and 40,738 outstanding in 2023)	849	464
Additional paid-in capital	551,591	548,304
Accumulated deficit	(553,719)	(549,945)
Treasury stock, at cost - 2024 - 0 shares; and 2023 - 5,672 shares	0	(5,168)
Total stockholders' equity (deficit)	(1,279)	(6,345)
Total liabilities and stockholders' equity (deficit)	$ 434	$ 78

Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.